Coloplast A/S | MedPath

Hilo Secures $42 Million Series B Funding to Revolutionize Blood Pressure Monitoring

14 days ago

• Hilo (formerly Aktiia) has raised $42 million in Series B funding to advance its cuffless blood pressure monitoring technology, bringing total financing to over $100 million. • The funding round was co-led by Earlybird Health and Wellington Partners, with participation from new investors Kfund and naturalX Health Ventures, alongside existing investors including Khosla Ventures. • With 120,000 devices sold and regulatory approvals in multiple countries, Hilo aims to address the global hypertension crisis where only 20% of affected individuals have their blood pressure under control.

Francis Medical Secures $80M Series C Funding for Innovative Water Vapor Ablation Technology

4 months ago

Francis Medical has successfully raised $80 million in Series C funding, led by Arboretum Ventures and Solas BioVentures, to advance its proprietary water vapor ablation therapy for treating prostate, kidney, and bladder cancer. The funds will support the VAPOR 2 pivotal clinical study and the U.S. commercialization of its Vanquish prostate cancer treatment, aiming for market entry by late 2025.

Johnson & Johnson MedTech Temporarily Pauses U.S. Varipulse Cases

5 months ago

Johnson & Johnson MedTech has announced a temporary pause on all U.S. cases using its Varipulse pulsed field ablation (PFA) system starting January 5, as it investigates the root cause of four reported issues.